Recombinant CD40 (Sotigalimab Biosimilar) antibody

Catalog No. ABIN7488337

The CHO Cells Monoclonal anti-CD40 (Sotigalimab Biosimilar) antibody has been validated for . It is suitable to detect CD40 (Sotigalimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD40 (Sotigalimab Biosimilar) antibody (ABIN7488337)

Target: CD40 (Sotigalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: CHO Cells

Clonality: Monoclonal

Conjugate: This CD40 (Sotigalimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD40 (Sotigalimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Sotigalimab Biosimilar - Anti-CD40 mAb

Characteristics: Antibody Type: IgG1,Kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD40 (Sotigalimab Biosimilar)

Target: CD40 (Sotigalimab Biosimilar)

Target Type: Biosimilar

Background: APX-005,IMMUNOGLOBULIN G1 (270-GLUTAMIC ACID, C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN CD40 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .KAPPA.-CHAIN, DIMER, CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M, EPI-0050